North America’s medical devices industry saw a drop of 2.20% in deal activity during May 2021, when compared with the last 12-month average, led by L.P, Canada Pension Plan Investment Board, ClearBridge Investments, Coatue Management, Columbia Threadneedle Investments, Eaton Vance, Fidelity Management & Research, First Light Asset Management, Highland Capital Management, Millennium Management, Orbimed Advisors, Pura Vida Investments, Rock Springs Capital Management, Silver Lake Management, T Rowe Price Associates, TPG Sixth Street Partners and Tudor Investment’s $830m acquisition of Caris Life Sciences, according to GlobalData’s deals database.
Go deeper with GlobalData
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
A total of 89 medical devices industry deals worth $4.6bn were announced for the region in May 2021, against the 12-month average of 91 deals.
Of all the deal types, venture financing saw most activity in May 2021 with 59 transactions, representing a 66.3% share for the region.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataIn second place was M&A with 21 deals, followed by private equity deals with nine transactions, respectively capturing a 23.6% and 10.1% share of the overall deal activity for the month.
In terms of value of deals, venture financing was the leading category in North America’s medical devices industry with $1.92bn, while private equity and M&A deals totalled $1.51bn and $1.18bn, respectively.
North America medical devices industry deals in May 2021: Top deals
The top five medical devices deals accounted for 52.5% of the overall value during May 2021.
The combined value of the top five medical devices deals stood at $2.42bn, against the overall value of $4.6bn recorded for the month.
The top five medical devices industry deals of May 2021 tracked by GlobalData were:
1) L.P, Canada Pension Plan Investment Board, ClearBridge Investments, Coatue Management, Columbia Threadneedle Investments, Eaton Vance, Fidelity Management & Research, First Light Asset Management, Highland Capital Management, Millennium Management, Orbimed Advisors, Pura Vida Investments, Rock Springs Capital Management, Silver Lake Management, T Rowe Price Associates, TPG Sixth Street Partners and Tudor Investment’s $830m private equity deal with Caris Life Sciences
2) The $550m acquisition deal with Soliton by Allergan Aesthetics
3) Novo Holdings, Oak HC/FT Partners, RRE Ventures, Samsung Ventures Investment, Sequoia Capital Operations, Silver Lake Management and Temasek Holdings (Private)’s $540m venture financing of Noom
4) The $260m acquisition of Nexcelom Bioscience by PerkinElmer
5) Dubilier & Rice, Clayton, Marathon Asset Management and Northwestern Mutual Capital’s private equity deal with Healogics for $240m.
